Multiplex PCR–Mass Spectrometry Mini-Sequencing Technology Detected Antibiotic Resistance of Helicobacter pylori to Six Antibiotics
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26041632 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Fei Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prev…. Hauptthemen laut MEDLINE: Helicobacter pylori, Anti-Bacterial Agents, Multiplex Polymerase Chain Reaction, Drug Resistance, Bacterial. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Capital's Funds for Health Improvement and Research, Capital’s Funds for Health Improvement and Research.
Abstract (Originalsprache)
The abuse of antibiotics has led to widespread resistance to Helicobacter pylori (H. pylori) in the population. There is an urgent need to establish a method to detect multiple antibiotic resistance rapidly. This study aimed to construct a novel strategy for the high-throughput detection of H. pylori’s resistance to varying antibiotics using multiplex PCR–mass spectrometry mini-sequencing (mPCR-MS mini-sequencing) technology. This study detected the resistance of H. pylori to six antibiotics using eight mutated sites (23S rRNA-2143; pbp1A-1667, 1684, 1240; gyrA-261, 271, 573; and 16S rRNA-928) of four resistance genes (pbp1A, gyrA, 23S rRNA, and 16S rRNA), and 525 were detected in all 528 results (99.43%). Then, the culture-based phenotypic drug susceptibility testing (DST) method was used as a reference for drug resistance detection. We found that the consistency rate between mPCR-MS mini-sequencing with the DST results of amoxicillin (AMX), moxifloxacin (MOX), levofloxacin (LEV), clarithromycin (CLA), azithromycin (AZI), and tetracycline (TET) were 95.5% (63/66), 77.3% (51/66), 68.2% (45/66), 93.9% (62/66), 92.4% (61/66), and 97.0% (64/66), respectively. This method was high-throughput and extensible, easily improving the entire detection system by adding new mutation sites. mPCR-MS mini-sequencing technology provides a new approach to mutation sites related to H. pylori’s antibiotic resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102…
ORCID-Profile: Xin Zhao, Jianzhong Zhang, Di Xiao
Förderung
- Capital's Funds for Health Improvement and Research
- Capital’s Funds for Health Improvement and Research
Zitieren
APA
Zhao, F., Zhao, X., Zhang, H., He, L., Meng, F., Zhang, J., & Xiao, D. (2025). Multiplex PCR–Mass Spectrometry Mini-Sequencing Technology Detected Antibiotic Resistance of Helicobacter pylori to Six Antibiotics. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26041632
Vancouver
Zhao F, Zhao X, Zhang H, He L, Meng F, Zhang J, et al. Multiplex PCR–Mass Spectrometry Mini-Sequencing Technology Detected Antibiotic Resistance of Helicobacter pylori to Six Antibiotics. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26041632
BibTeX
@article{Zhao2025,
author = {Zhao, Fei and Zhao, Xin and Zhang, Huifang and He, Lihua and Meng, Fanliang and Zhang, Jianzhong and Xiao, Di},
title = {Multiplex PCR–Mass Spectrometry Mini-Sequencing Technology Detected Antibiotic Resistance of Helicobacter pylori to Six Antibiotics},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26041632}
}
EUVIMED